Vascular & Endovascular

This channel includes news on non-coronary vascular disease and therapies. These include peripheral artery disease (PAD), abdominal and thoracic aortic aneurysm (AAA and TAA), aortic dissection, pulmonary embolism (PE), critical limb ischemia (CLI), carotid artery and stroke interventions, venous interventions, deep vein thrombosis (DVT), and interventional radiology therapies. The focus on most of these therapies is minimally invasive, catheter-based procedures performed in a cath lab.

‘Fundamental for all patients’: Exploring the benefits of palliative care for stroke survivors
Approximately 800,000 strokes occur each year in the United States alone. A majority of people survive, due in part to key advances in patient care over the years, but they often go forward without receiving the long-term help they need to recover and thrive.
Advancing AI for vascular surgery will require a commitment to data integrity
For artificial intelligence to truly transform care, the healthcare industry must address certain challenges. Jens Eldrup-Jorgensen, MD, a veteran vascular surgeon and member of the Society for Vascular Surgery, explains in a guest editorial.
Industry concerns over paclitaxel-coated devices may have put PAD patients at risk
Back in 2019, the FDA issued a warning about the use of paclitaxel-coated devices when treating peripheral artery disease. The agency took back that warning in 2023, but it appears to have made a significant impact on patient care.
Genetic predisposition to depression increases CVD risk in women, but not men
The heightened risks were even seen in women who were never diagnosed with a psychiatric disorder. It remains unclear why the same trend was not seen in men.
Clopidogrel vs. aspirin: Tracking the chronic maintenance period after PCI for different risk groups
As more high-risk patients undergo PCI, what is the best antiplatelet strategy following an initial event-free period of DAPT? Does it change after complex PCI? Researchers aimed to answer these questions, and many others, with new findings published in JAMA Cardiology.

Example of intravascular ultrasound (IVUS) shown as part of the multimodality imaging capability on the Fujifilm CVIS.

Intravascular imaging-guided PCI improves patient outcomes, new meta-analysis confirms

The ILUMIEN IV and OCTOBER trials helped illustrate that the benefits of intravascular ultrasound also are seen with optical coherence tomography. Both trials were included in the new meta-analysis presented at ESC Congress 2023.

August 28, 2023

Texas researchers receive $1.14M to develop first CVD drug of its kind

If successful, the group's first-in-class medication would be able to target inflammation in CVD patients before it even occurs.

August 25, 2023

device implantation during left atrial appendage occlusion (LAAO) procedures

Mitigating risk: How the depth of device implantation impacts LAAO outcomes

Researchers examined data from more than 1,300 procedures, presenting their findings in JACC: Cardiovascular Interventions.

August 18, 2023

Abiomed recalls heart pump catheter labeling after 12 injuries

This is a Class I recall, which means using the devices “may cause serious injuries or death.” The catheter's instructions have been updated to reduce the risk of complications going forward.

August 18, 2023

How the 2022 contrast media shortage impacted stroke care

A team of specialists tracked CT utilization before, during and after the 2022 shortage, sharing its findings in the American Journal of Neuroradiology.

August 16, 2023

Vienna Aortic Self-Expandable Transcatheter Valve premounted on the delivery system

New TAVR valve, premounted to save cardiologists time, linked to promising 30-day outcomes

The new valve arrives fully premounted on a delivery system and was designed to allow resheathing or complete recapture/redeployment if necessary.

August 16, 2023

doctor with overweight patient who may be treated with TAVR or surgery

Weight loss drug semaglutide could boost heart health of up to 93M patients in US alone

Researchers have recently determined that the medication, originally developed to treat diabetes, can contribute to weight loss and reduce a patient's MACE risk by up to 20%.

August 15, 2023

alternative approaches for transcatheter aortic valve replacement procedures

Alternative TAVR techniques: How to proceed when transfemoral access is not recommended

A team of researchers from the United States and Sweden explored data from nearly 12,000 TAVR patients for a new systematic review and meta-analysis.

August 11, 2023

Vascular & Endovascular

‘Fundamental for all patients’: Exploring the benefits of palliative care for stroke survivors

Advancing AI for vascular surgery will require a commitment to data integrity

Industry concerns over paclitaxel-coated devices may have put PAD patients at risk

Genetic predisposition to depression increases CVD risk in women, but not men

Clopidogrel vs. aspirin: Tracking the chronic maintenance period after PCI for different risk groups